Screener
Eligibility screening
Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD
2 US sites in CA, RI
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD
2 US sites in CA, RI
Before we begin
Your answer affects how the questions are phrased.